Bandingkan Harga & Kinerja Cipta Sarana Medika Tbk. (DKHH) vs Mizuho Leasing Indonesia Tbk. (VRNA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Cipta Sarana Medika Tbk. dan Mizuho Leasing Indonesia Tbk.: Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt), sedangkan Mizuho Leasing Indonesia Tbk. diperdagangkan di Rp75 (kapitalisasi pasar 426,55 M, volume 24 jam 1,06 jt). Perbedaan utamanya: Mizuho Leasing Indonesia Tbk. jauh lebih besar — sekitar 2,7× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Cipta Sarana Medika Tbk. lebih aktif diperdagangkan (8,21 jt vs 1,06 jt). Mana yang lebih baik tergantung tujuan investasimu.
| DKHH | VRNA | |
|---|---|---|
Kapitalisasi Pasar | 158,12 M | 426,55 M |
Volume | 8,21 jt | 1,06 jt |
Lot | 82,15 rb | 10,63 rb |
Perputaran | 515,2 jt | 82,27 jt |
Harga Rata-rata | 62,72 | 77,4 |
Nilai Transaksi | 515,2 jt | 82,27 jt |
Harga Ekuilibrium Indikatif | 63 | 75 |
Volume Ekuilibrium Indikatif | 1,33 rb | 90 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →Tentang Mizuho Leasing Indonesia Tbk.
PT Verena Oto Finance (the Company) was established under its original name of PT Maxima Perdana Finance base on notarial deed No.43 of Mrs Sri Nanning, S.H, dated on Jul 21, 1993. The Companys articles of association has been amended several times, most recently by notarial deed No. 32 of Fathiah Helmi, S.H., dated Mar 26, 2007, concerning among others, the change in the Companys name, increase authorized, change in par value, and increase paid-up capital.
Selengkapnya di halaman VRNA →
